Literature DB >> 17428731

SELEX experiments: new prospects, applications and data analysis in inferring regulatory pathways.

Marko Djordjevic1.   

Abstract

Systematic Evolution of Ligands by EXponential enrichment (SELEX) is an experimental procedure that allows extraction, from an initially random pool of oligonucleotides, of the oligomers with a desired binding affinity for a given molecular target. The procedure can be used to infer the strongest binders for a given DNA or RNA binding protein, and the highest affinity binding sequences isolated through SELEX can have numerous research, diagnostic and therapeutic applications. Recently, important new modifications of the SELEX protocol have been proposed. In particular, a modification of the standard SELEX procedure allows generating a dataset from which protein-DNA interaction parameters can be determined with unprecedented accuracy. Another variant of SELEX allows investigating interactions of a protein with nucleic-acid fragments derived from the entire genome of an organism. We review here different SELEX-based methods, with particular emphasis on the experimental design and on the applications aimed at inferring protein-DNA interactions. In addition to the experimental issues, we also review relevant methods of data analysis, as well as theoretical modeling of SELEX.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428731     DOI: 10.1016/j.bioeng.2007.03.001

Source DB:  PubMed          Journal:  Biomol Eng        ISSN: 1389-0344


  42 in total

1.  Determination of target sequence bound by PapX, repressor of bacterial motility, in flhD promoter using systematic evolution of ligands by exponential enrichment (SELEX) and high throughput sequencing.

Authors:  Daniel J Reiss; Harry L T Mobley
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

2.  The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops.

Authors:  Qing Xie; Ales Cvekl
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

3.  Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing.

Authors:  Minseon Cho; Yi Xiao; Jeff Nie; Ron Stewart; Andrew T Csordas; Seung Soo Oh; James A Thomson; H Tom Soh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-12       Impact factor: 11.205

Review 4.  Experimental strategies for studying transcription factor-DNA binding specificities.

Authors:  Marcel Geertz; Sebastian J Maerkl
Journal:  Brief Funct Genomics       Date:  2010-09-23       Impact factor: 4.241

5.  Determination of minimal sequence for zearalenone aptamer by computational docking and application on an indirect competitive electrochemical aptasensor.

Authors:  Farah Asilah Azri; Jinap Selamat; Rashidah Sukor; Nor Azah Yusof; Nurul Hanun Ahmad Raston; Shimaa Eissa; Mohammed Zourob; Raja Chinnappan
Journal:  Anal Bioanal Chem       Date:  2021-05-21       Impact factor: 4.142

6.  Formation of the open complex by bacterial RNA polymerase--a quantitative model.

Authors:  Marko Djordjevic; Ralf Bundschuh
Journal:  Biophys J       Date:  2008-02-15       Impact factor: 4.033

Review 7.  Mechanisms and evolution of control logic in prokaryotic transcriptional regulation.

Authors:  Sacha A F T van Hijum; Marnix H Medema; Oscar P Kuipers
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

8.  Identifying splicing regulatory elements with de Bruijn graphs.

Authors:  Eman Badr; Lenwood S Heath
Journal:  J Comput Biol       Date:  2014-12       Impact factor: 1.479

Review 9.  Long Non-coding RNAs and their Role in Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Rüdiger Rüger
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

10.  Characterization of homing endonuclease binding and cleavage specificities using yeast surface display SELEX (YSD-SELEX).

Authors:  Kyle Jacoby; Abigail R Lambert; Andrew M Scharenberg
Journal:  Nucleic Acids Res       Date:  2017-02-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.